Compare Cassava Sciences Inc (FLNA) vs Mongodb Inc (MDB) Price & Performance

FLNA trades at $0.84, up 2.72% today, with a bearish technical signal despite recent earnings beats. The company shows negative profitability metrics with ROE at -55.79% and ROA at -35.34%, though valuation ratios like EV/EBITDA of 1.03 and P/B of 0.62 suggest potential undervaluation. Recent FDA clearance for epilepsy drug trials provides a positive catalyst, but negative cash flow trends and zero revenue remain concerns.

The outlook hinges on clinical trial success and revenue generation. Analyst consensus is bullish with 67% buy ratings, but high execution risk and cash burn require careful monitoring. Near-term catalysts include Phase 2a trial initiation in 2027, while financial sustainability remains the primary challenge for investors.

MDB trades at $383.26, up 5.57% today, with a bullish technical signal and strong analyst support. The stock is near resistance at $384 after recent volatility from a CEO transition. Fundamentally, revenue growth is robust, reaching $2.01B in 2025, but profitability remains negative with a net loss of $129M. Recent Investor Day highlighted AI product launches and raised long-term targets, fueling optimism.

Outlook is positive with 80% analyst buy ratings and a $456.76 consensus target, but risks include persistent losses, high valuation multiples, and execution challenges amid leadership changes. The stock offers growth exposure to AI-driven database demand, yet investors must weigh profitability concerns against expansion potential.